The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl 6-(2-(4-chlorophenyl)-4-oxo-1,2-dihydroquinazolin-3(4H)-yl)hexanoate ID: ALA3585836
PubChem CID: 122179907
Max Phase: Preclinical
Molecular Formula: C21H23ClN2O3
Molecular Weight: 386.88
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)CCCCCN1C(=O)c2ccccc2NC1c1ccc(Cl)cc1
Standard InChI: InChI=1S/C21H23ClN2O3/c1-27-19(25)9-3-2-6-14-24-20(15-10-12-16(22)13-11-15)23-18-8-5-4-7-17(18)21(24)26/h4-5,7-8,10-13,20,23H,2-3,6,9,14H2,1H3
Standard InChI Key: RTJIQNVMLFXIFM-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2928 2.6973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9122 1.4966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2109 0.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5121 1.4924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8109 0.7403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1121 1.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.4109 0.7361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.7121 1.4840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.4090 -0.4639 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-12.7505 0.8826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9097 -3.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2093 -3.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5078 -3.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2071 -0.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5067 -1.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5474 -3.6002 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 1 0
2 3 1 0
3 4 1 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
1 11 2 0
2 12 1 0
3 13 1 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
13 22 2 0
22 23 1 0
23 24 2 0
24 26 1 0
25 13 1 0
25 26 2 0
24 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.88Molecular Weight (Monoisotopic): 386.1397AlogP: 4.64#Rotatable Bonds: 7Polar Surface Area: 58.64Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.46CX Basic pKa: ┄CX LogP: 4.92CX LogD: 4.92Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.56Np Likeness Score: -0.75
References 1. Khattab SN, Haiba NS, Asal AM, Bekhit AA, Amer A, Abdel-Rahman HM, El-Faham A.. (2015) Synthesis and evaluation of quinazoline amino acid derivatives as mono amine oxidase (MAO) inhibitors., 23 (13): [PMID:25922182 ] [10.1016/j.bmc.2015.04.021 ]